speb/financial-data huggingface dataset:
CLX.L balance_sheet (annual, 2024-03-31) — Tangible Book Value: 13228000.00
CLX.L income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
CLX.L income_statement (annual, 2024-03-31) — Tax Provision: -424000.00
CLX.L income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
CLX.L balance_sheet (annual, 2024-03-31) — Taxes Receivable: 435000.00
CLX.L cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -850000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Assets: 37000000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Capitalization: 27338000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Debt: 415000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 27338000.00
CLX.L income_statement (annual, 2024-03-31) — Total Expenses: 16891000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 9662000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 15984000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 4597000.00
CLX.L income_statement (annual, 2024-03-31) — Total Operating Income As Reported: -617000.00
CLX.L balance_sheet (annual, 2024-03-31) — Total Tax Payable: 211000.00
CLX.L income_statement (annual, 2024-03-31) — Total Unusual Items: -104000.00
CLX.L income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -104000.00
CLX.L balance_sheet (annual, 2024-03-31) — Working Capital: 15951000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 400000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2589000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -425000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Additional Paid In Capital: 7511000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 274000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Capital Stock: 109000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 8580000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 8580000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Cash Equivalents: 0.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Cash Financial: 8580000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Common Stock: 109000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 26206000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Current Assets: 18770000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 127000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 127000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 3385000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Finished Goods: 6086000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Goodwill: 2000000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 14483000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Gross Accounts Receivable: 2589000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Gross PPE: 865000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Inventory: 6086000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Invested Capital: 26206000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 147000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 147000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 15000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 696000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Net PPE: 440000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 11723000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Revenue: 1976000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 533000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 2497000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 87558302.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 1814000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 12483000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Other Payable: 91000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Other Properties: 169000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Other Receivables: 367000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Payables: 695000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Retained Earnings: 16772000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Share Issued: 87558302.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 26206000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 11723000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 1148000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Assets: 34226000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 26206000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Debt: 274000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 26206000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 8020000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 15456000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 4635000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 204000.00
CLX.L balance_sheet (quarterly, 2024-09-30) — Working Capital: 15385000.00
CLX.L income_statement (annual, 2025-03-31) — +Operating Expense: 13326000.00
CLX.L income_statement (annual, 2025-03-31) — +Total Revenue: 18386000.00
CLX.L balance_sheet (annual, 2025-03-31) — Accounts Payable: 987000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 987000.00
CLX.L balance_sheet (annual, 2025-03-31) — Accounts Receivable: 5313000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 5313000.00
CLX.L balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -839000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -839000.00
CLX.L balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 7671000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 7671000.00
CLX.L cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 4803000.00
CLX.L income_statement (annual, 2025-03-31) — Basic Average Shares: 87614000.00
CLX.L income_statement (annual, 2025-03-31) — Basic EPS: 0.00
CLX.L cash_flow (annual, 2025-03-31) — Beginning Cash Position: 11868000.00
CLX.L balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1362000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1362000.00
CLX.L cash_flow (annual, 2025-03-31) — Capital Expenditure: -4892000.00
CLX.L balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 1217000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1217000.00
CLX.L balance_sheet (annual, 2025-03-31) — Capital Stock: 110000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Capital Stock: 110000.00
CLX.L balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 10912000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 10912000.00
CLX.L balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10912000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 10912000.00
CLX.L cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -814000.00
CLX.L balance_sheet (annual, 2025-03-31) — Cash Equivalents: 126000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 126000.00
CLX.L balance_sheet (annual, 2025-03-31) — Cash Financial: 10786000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Cash Financial: 10786000.00
CLX.L cash_flow (annual, 2025-03-31) — Change In Inventory: -405000.00
CLX.L cash_flow (annual, 2025-03-31) — Change In Payable: 738000.00
CLX.L cash_flow (annual, 2025-03-31) — Change In Receivables: -2334000.00
CLX.L cash_flow (annual, 2025-03-31) — Change In Working Capital: -1580000.00
CLX.L cash_flow (annual, 2025-03-31) — Changes In Cash: -956000.00
CLX.L balance_sheet (annual, 2025-03-31) — Common Stock: 110000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Common Stock: 110000.00
CLX.L cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -814000.00
CLX.L balance_sheet (annual, 2025-03-31) — Common Stock Equity: 27444000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 27444000.00
CLX.L cash_flow (annual, 2025-03-31) — Common Stock Issuance: 161000.00
CLX.L income_statement (annual, 2025-03-31) — Cost Of Revenue: 4623000.00
CLX.L balance_sheet (annual, 2025-03-31) — Current Assets: 22623000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Current Assets: 22623000.00
CLX.L balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 289000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 289000.00
CLX.L balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 289000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 289000.00
CLX.L balance_sheet (annual, 2025-03-31) — Current Liabilities: 5756000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 5756000.00
CLX.L cash_flow (annual, 2025-03-31) — Deferred Tax: -713000.00
CLX.L cash_flow (annual, 2025-03-31) — Depreciation: 182000.00
CLX.L cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 4985000.00
CLX.L income_statement (annual, 2025-03-31) — Diluted Average Shares: 92852000.00
CLX.L income_statement (annual, 2025-03-31) — Diluted EPS: 0.00
CLX.L income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 337000.00
CLX.L income_statement (annual, 2025-03-31) — EBIT: 757000.00
CLX.L income_statement (annual, 2025-03-31) — EBITDA: 5742000.00
CLX.L cash_flow (annual, 2025-03-31) — End Cash Position: 10912000.00
CLX.L cash_flow (annual, 2025-03-31) — Financing Cash Flow: -967000.00
CLX.L balance_sheet (annual, 2025-03-31) — Finished Goods: 5358000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Finished Goods: 5358000.00
CLX.L cash_flow (annual, 2025-03-31) — Free Cash Flow: -309000.00
CLX.L cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
CLX.L income_statement (annual, 2025-03-31) — General And Administrative Expense: 14239000.00
CLX.L balance_sheet (annual, 2025-03-31) — Goodwill: 2000000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Goodwill: 2000000.00
CLX.L balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 14255000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 14255000.00
CLX.L balance_sheet (annual, 2025-03-31) — Gross PPE: 2141000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2141000.00
CLX.L income_statement (annual, 2025-03-31) — Gross Profit: 13763000.00
CLX.L income_statement (annual, 2025-03-31) — Interest Expense: 37000.00
CLX.L income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 37000.00
CLX.L income_statement (annual, 2025-03-31) — Interest Income: 320000.00
CLX.L income_statement (annual, 2025-03-31) — Interest Income Non Operating: 320000.00
CLX.L cash_flow (annual, 2025-03-31) — Interest Received Cfi: 320000.00
CLX.L balance_sheet (annual, 2025-03-31) — Inventory: 5358000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Inventory: 5358000.00
CLX.L balance_sheet (annual, 2025-03-31) — Invested Capital: 27444000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Invested Capital: 27444000.00
CLX.L cash_flow (annual, 2025-03-31) — Investing Cash Flow: -4572000.00
CLX.L cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 161000.00
CLX.L balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 928000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 928000.00
CLX.L balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 928000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 928000.00
CLX.L balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 779000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 779000.00
CLX.L cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 161000.00
CLX.L income_statement (annual, 2025-03-31) — Net Income: 337000.00
CLX.L income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 337000.00
CLX.L income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 337000.00
CLX.L income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 337000.00
CLX.L income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 337000.00
CLX.L cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 720000.00
CLX.L income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 337000.00
CLX.L cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -4864000.00
CLX.L income_statement (annual, 2025-03-31) — Net Interest Income: 283000.00
CLX.L cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 0.00
CLX.L income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: 283000.00
CLX.L balance_sheet (annual, 2025-03-31) — Net PPE: 1302000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Net PPE: 1302000.00
CLX.L cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -28000.00
CLX.L balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 13189000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13189000.00
CLX.L balance_sheet (annual, 2025-03-31) — Non Current Deferred Revenue: 1411000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 1411000.00
CLX.L balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 299000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 299000.00
CLX.L balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2940000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 2940000.00
CLX.L income_statement (annual, 2025-03-31) — Normalized EBITDA: 5742000.00
CLX.L income_statement (annual, 2025-03-31) — Normalized Income: 337000.00
CLX.L cash_flow (annual, 2025-03-31) — Operating Cash Flow: 4583000.00
CLX.L income_statement (annual, 2025-03-31) — Operating Income: 437000.00
CLX.L income_statement (annual, 2025-03-31) — Operating Revenue: 18386000.00
CLX.L balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 87891636.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 87891636.00
CLX.L balance_sheet (annual, 2025-03-31) — Other Equity Interest: 1764000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 1764000.00
CLX.L balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 12255000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 12255000.00
CLX.L cash_flow (annual, 2025-03-31) — Other Non Cash Items: -483000.00
CLX.L income_statement (annual, 2025-03-31) — Other Operating Expenses: -713000.00
CLX.L balance_sheet (annual, 2025-03-31) — Other Payable: 88000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Other Payable: 88000.00
CLX.L balance_sheet (annual, 2025-03-31) — Other Receivables: 356000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Other Receivables: 356000.00
CLX.L income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CLX.L balance_sheet (annual, 2025-03-31) — Payables: 1301000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Payables: 1301000.00
CLX.L income_statement (annual, 2025-03-31) — Pretax Income: 720000.00
CLX.L balance_sheet (annual, 2025-03-31) — Properties: 0.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CLX.L cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -4864000.00
CLX.L cash_flow (annual, 2025-03-31) — Purchase Of PPE: -28000.00
CLX.L income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 4623000.00
CLX.L income_statement (annual, 2025-03-31) — Reconciled Depreciation: 4985000.00
CLX.L balance_sheet (annual, 2025-03-31) — Retained Earnings: 17899000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 17899000.00
CLX.L income_statement (annual, 2025-03-31) — Selling General And Administration: 14239000.00
CLX.L balance_sheet (annual, 2025-03-31) — Share Issued: 87891636.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Share Issued: 87891636.00
CLX.L cash_flow (annual, 2025-03-31) — Stock Based Compensation: 432000.00
CLX.L balance_sheet (annual, 2025-03-31) — Stockholders Equity: 27444000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 27444000.00
CLX.L balance_sheet (annual, 2025-03-31) — Tangible Book Value: 13189000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13189000.00
CLX.L income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CLX.L income_statement (annual, 2025-03-31) — Tax Provision: 383000.00
CLX.L income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
CLX.L balance_sheet (annual, 2025-03-31) — Taxes Receivable: 684000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 684000.00
CLX.L cash_flow (annual, 2025-03-31) — Taxes Refund Paid: 1070000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Assets: 38479000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Assets: 38479000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Capitalization: 27444000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 27444000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Debt: 1217000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Debt: 1217000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 27444000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 27444000.00
CLX.L income_statement (annual, 2025-03-31) — Total Expenses: 17949000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 11035000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 11035000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 15856000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 15856000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5279000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 5279000.00
CLX.L income_statement (annual, 2025-03-31) — Total Operating Income As Reported: 437000.00
CLX.L balance_sheet (annual, 2025-03-31) — Total Tax Payable: 226000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 226000.00
CLX.L balance_sheet (annual, 2025-03-31) — Working Capital: 16867000.00
CLX.L balance_sheet (quarterly, 2025-03-31) — Working Capital: 16867000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 655000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2425000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -602000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7703000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1080000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Capital Stock: 110000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 10303000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 10303000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 0.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Cash Financial: 10303000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Common Stock: 110000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 26627000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Current Assets: 19609000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 261000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 261000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4476000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Finished Goods: 5248000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Goodwill: 2000000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14633000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Gross PPE: 1758000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Inventory: 5248000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Invested Capital: 26627000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 819000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 819000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 779000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Net PPE: 1156000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 11994000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 1102000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 566000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 2940000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 87991636.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2164000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 12633000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Other Payable: 103000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Other Properties: 979000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Other Receivables: 615000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Payables: 992000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 16650000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Share Issued: 87991636.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 26627000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 11994000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 1018000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Assets: 35964000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 26627000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Debt: 1080000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 26627000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 9337000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 16355000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 4861000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 234000.00
CLX.L balance_sheet (quarterly, 2025-09-30) — Working Capital: 15133000.00
CLYM balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 24919000.00
CLYM balance_sheet (annual, 2021-12-31) — Cash Financial: 46922000.00
CLYM balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 0.00
CLYM cash_flow (annual, 2021-12-31) — Net Preferred Stock Issuance: 93939000.00
CLYM balance_sheet (annual, 2021-12-31) — Other Current Assets: 852000.00
CLYM balance_sheet (annual, 2021-12-31) — Other Non Current Liabilities: 7000.00
CLYM income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -11638000.00
CLYM income_statement (annual, 2021-12-31) — Other Operating Expenses: 11718000.00
CLYM income_statement (annual, 2021-12-31) — Otherunder Preferred Stock Dividend: 4548000.00
CLYM balance_sheet (annual, 2021-12-31) — Preferred Stock: 0.00
CLYM cash_flow (annual, 2021-12-31) — Preferred Stock Issuance: 93939000.00
CLYM balance_sheet (annual, 2021-12-31) — Receivables: 6523000.00
CLYM income_statement (annual, 2021-12-31) — Special Income Charges: 0.00
CLYM balance_sheet (annual, 2021-12-31) — Taxes Receivable: 6523000.00
CLYM income_statement (annual, 2022-12-31) — +Operating Expense: 45135000.00
CLYM income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Accounts Payable: 750000.00
CLYM balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 249930000.00
CLYM cash_flow (annual, 2022-12-31) — Amortization Of Securities: -177000.00
CLYM cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CLYM income_statement (annual, 2022-12-31) — Basic Average Shares: 26311554.00
CLYM income_statement (annual, 2022-12-31) — Basic EPS: -1.72
CLYM cash_flow (annual, 2022-12-31) — Beginning Cash Position: 46922000.00
CLYM balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 480000.00
CLYM balance_sheet (annual, 2022-12-31) — Capital Stock: 3000.00
CLYM balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 43585000.00
CLYM balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 123566000.00
CLYM balance_sheet (annual, 2022-12-31) — Cash Equivalents: 43585000.00
CLYM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 0.00
CLYM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 34440000.00
CLYM cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -37369000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Account Payable: -653000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 425000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -60000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -447000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Payable: -653000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -228000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 945000.00
CLYM cash_flow (annual, 2022-12-31) — Change In Working Capital: 210000.00
CLYM cash_flow (annual, 2022-12-31) — Changes In Cash: -2929000.00
CLYM balance_sheet (annual, 2022-12-31) — Common Stock: 3000.00
CLYM balance_sheet (annual, 2022-12-31) — Common Stock Equity: 128715000.00
CLYM cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 5047000.00
CLYM balance_sheet (annual, 2022-12-31) — Current Assets: 134393000.00
CLYM balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 300000.00
CLYM balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 300000.00
CLYM balance_sheet (annual, 2022-12-31) — Current Liabilities: 6097000.00
CLYM income_statement (annual, 2022-12-31) — Diluted Average Shares: 26311554.00
CLYM income_statement (annual, 2022-12-31) — Diluted EPS: -1.72
CLYM income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -45244000.00
CLYM income_statement (annual, 2022-12-31) — EBIT: -45135000.00
CLYM income_statement (annual, 2022-12-31) — EBITDA: -45135000.00
CLYM cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -408000.00
CLYM cash_flow (annual, 2022-12-31) — End Cash Position: 43585000.00
CLYM cash_flow (annual, 2022-12-31) — Financing Cash Flow: 0.00
CLYM cash_flow (annual, 2022-12-31) — Free Cash Flow: -37369000.00
CLYM income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -1484000.00
CLYM balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -358000.00
CLYM income_statement (annual, 2022-12-31) — General And Administrative Expense: 18921000.00
CLYM balance_sheet (annual, 2022-12-31) — Gross PPE: 471000.00
CLYM income_statement (annual, 2022-12-31) — Interest Income: 1375000.00
CLYM income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1375000.00
CLYM balance_sheet (annual, 2022-12-31) — Invested Capital: 128715000.00
CLYM cash_flow (annual, 2022-12-31) — Investing Cash Flow: 34440000.00
CLYM balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Investments And Advances: 0.00
CLYM cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 180000.00
CLYM balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 180000.00
CLYM cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CLYM cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 408000.00
CLYM income_statement (annual, 2022-12-31) — Net Income: -45244000.00
CLYM income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -45244000.00
CLYM income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -45244000.00
CLYM income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -45244000.00
CLYM income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -45244000.00
CLYM cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -45244000.00
CLYM income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -45244000.00
CLYM income_statement (annual, 2022-12-31) — Net Interest Income: 1375000.00
CLYM cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 34440000.00
CLYM income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: 1375000.00
CLYM balance_sheet (annual, 2022-12-31) — Net PPE: 471000.00
CLYM cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 128715000.00
CLYM income_statement (annual, 2022-12-31) — Normalized EBITDA: -43651000.00
CLYM income_statement (annual, 2022-12-31) — Normalized Income: -43760000.00
CLYM cash_flow (annual, 2022-12-31) — Operating Cash Flow: -37369000.00
CLYM cash_flow (annual, 2022-12-31) — Operating Gains Losses: 408000.00
CLYM income_statement (annual, 2022-12-31) — Operating Income: -45135000.00
CLYM income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 26567681.00
CLYM balance_sheet (annual, 2022-12-31) — Other Current Assets: 3005000.00
CLYM balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -358000.00
CLYM income_statement (annual, 2022-12-31) — Other Gand A: 18921000.00
CLYM income_statement (annual, 2022-12-31) — Other Income Expense: -1484000.00
CLYM cash_flow (annual, 2022-12-31) — Other Non Cash Items: 443000.00
CLYM balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 128000.00
CLYM income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 1375000.00
CLYM balance_sheet (annual, 2022-12-31) — Other Properties: 471000.00
CLYM balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 79981000.00
CLYM income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Payables: 750000.00
CLYM balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 5797000.00
CLYM cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Prepaid Assets: 1330000.00
CLYM income_statement (annual, 2022-12-31) — Pretax Income: -45244000.00
CLYM cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CLYM cash_flow (annual, 2022-12-31) — Purchase Of Investment: -87963000.00
CLYM balance_sheet (annual, 2022-12-31) — Receivables: 6492000.00
CLYM income_statement (annual, 2022-12-31) — Research And Development: 26214000.00
CLYM balance_sheet (annual, 2022-12-31) — Retained Earnings: -120860000.00
CLYM cash_flow (annual, 2022-12-31) — Sale Of Investment: 122403000.00
CLYM income_statement (annual, 2022-12-31) — Selling General And Administration: 18921000.00
CLYM balance_sheet (annual, 2022-12-31) — Share Issued: 26567681.00
CLYM cash_flow (annual, 2022-12-31) — Stock Based Compensation: 6991000.00
CLYM balance_sheet (annual, 2022-12-31) — Stockholders Equity: 128715000.00
CLYM balance_sheet (annual, 2022-12-31) — Tangible Book Value: 128715000.00
CLYM income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLYM income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLYM balance_sheet (annual, 2022-12-31) — Taxes Receivable: 6492000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Assets: 134992000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Capitalization: 128715000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Debt: 480000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 128715000.00
CLYM income_statement (annual, 2022-12-31) — Total Expenses: 45135000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 6277000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 599000.00
CLYM balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 180000.00
CLYM income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -45135000.00
CLYM income_statement (annual, 2022-12-31) — Total Unusual Items: -1484000.00
CLYM income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1484000.00
CLYM balance_sheet (annual, 2022-12-31) — Working Capital: 128296000.00
CLYM income_statement (annual, 2023-12-31) — +Operating Expense: 40275000.00
CLYM income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
CLYM balance_sheet (annual, 2023-12-31) — Accounts Payable: 66000.00
CLYM balance_sheet (annual, 2023-12-31) — Accrued Interest Receivable: 440000.00
CLYM balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 263577000.00
CLYM cash_flow (annual, 2023-12-31) — Amortization Of Securities: -2331000.00
CLYM cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 180000.00
CLYM income_statement (annual, 2023-12-31) — Basic Average Shares: 26987122.00
CLYM income_statement (annual, 2023-12-31) — Basic EPS: -1.30
CLYM cash_flow (annual, 2023-12-31) — Beginning Cash Position: 43585000.00
CLYM balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 349000.00
CLYM balance_sheet (annual, 2023-12-31) — Capital Stock: 3000.00
CLYM balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 93112000.00
CLYM balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 106798000.00
CLYM balance_sheet (annual, 2023-12-31) — Cash Equivalents: 93112000.00
CLYM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 841000.00
CLYM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 68981000.00
CLYM cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -20599000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Account Payable: -686000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -2613000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 115000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -422000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Payable: -686000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -3299000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 7370000.00
CLYM cash_flow (annual, 2023-12-31) — Change In Working Capital: 3764000.00
CLYM cash_flow (annual, 2023-12-31) — Changes In Cash: 49223000.00
CLYM balance_sheet (annual, 2023-12-31) — Common Stock: 3000.00
CLYM balance_sheet (annual, 2023-12-31) — Common Stock Equity: 107599000.00
CLYM cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CLYM balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 2295000.00
CLYM balance_sheet (annual, 2023-12-31) — Current Assets: 110255000.00
CLYM balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 334000.00
CLYM balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 334000.00
CLYM balance_sheet (annual, 2023-12-31) — Current Liabilities: 2833000.00
CLYM income_statement (annual, 2023-12-31) — Diluted Average Shares: 26987122.00
CLYM income_statement (annual, 2023-12-31) — Diluted EPS: -1.30
CLYM income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -35119000.00
CLYM income_statement (annual, 2023-12-31) — EBIT: -40275000.00
CLYM income_statement (annual, 2023-12-31) — EBITDA: -40275000.00
CLYM cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 304000.00
CLYM cash_flow (annual, 2023-12-31) — End Cash Position: 93112000.00
CLYM cash_flow (annual, 2023-12-31) — Financing Cash Flow: 841000.00
CLYM cash_flow (annual, 2023-12-31) — Free Cash Flow: -20599000.00
CLYM income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 536000.00
CLYM balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2000.00
CLYM income_statement (annual, 2023-12-31) — General And Administrative Expense: 24864000.00
CLYM balance_sheet (annual, 2023-12-31) — Gross PPE: 199000.00
CLYM income_statement (annual, 2023-12-31) — Interest Income: 4620000.00
CLYM income_statement (annual, 2023-12-31) — Interest Income Non Operating: 4620000.00
CLYM balance_sheet (annual, 2023-12-31) — Invested Capital: 107599000.00
CLYM cash_flow (annual, 2023-12-31) — Investing Cash Flow: 68981000.00
CLYM balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 0.00
CLYM balance_sheet (annual, 2023-12-31) — Investments And Advances: 0.00
CLYM cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CLYM balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 15000.00
CLYM balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 15000.00
CLYM cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CLYM cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -304000.00
CLYM income_statement (annual, 2023-12-31) — Net Income: -35119000.00
CLYM income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -35119000.00
CLYM income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -35119000.00
CLYM income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -35119000.00
CLYM income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -35119000.00
CLYM cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -35119000.00
CLYM income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -35119000.00
CLYM income_statement (annual, 2023-12-31) — Net Interest Income: 4620000.00
CLYM cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 68981000.00
CLYM income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 4620000.00
CLYM balance_sheet (annual, 2023-12-31) — Net PPE: 199000.00
CLYM balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 107599000.00
CLYM income_statement (annual, 2023-12-31) — Normalized EBITDA: -40811000.00
CLYM income_statement (annual, 2023-12-31) — Normalized Income: -35655000.00
CLYM cash_flow (annual, 2023-12-31) — Operating Cash Flow: -20599000.00
CLYM cash_flow (annual, 2023-12-31) — Operating Gains Losses: -304000.00
CLYM income_statement (annual, 2023-12-31) — Operating Income: -40275000.00
CLYM income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
CLYM balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 27699446.00
CLYM balance_sheet (annual, 2023-12-31) — Other Current Assets: 112000.00
CLYM balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 138000.00
CLYM balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2000.00
CLYM income_statement (annual, 2023-12-31) — Other Gand A: 24864000.00
CLYM income_statement (annual, 2023-12-31) — Other Income Expense: 536000.00
CLYM cash_flow (annual, 2023-12-31) — Other Non Cash Items: 405000.00
CLYM balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 15000.00
CLYM balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 22000.00
CLYM balance_sheet (annual, 2023-12-31) — Other Properties: 199000.00
CLYM balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 13686000.00
CLYM balance_sheet (annual, 2023-12-31) — Payables: 66000.00
CLYM balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 2361000.00
CLYM balance_sheet (annual, 2023-12-31) — Prepaid Assets: 881000.00
CLYM income_statement (annual, 2023-12-31) — Pretax Income: -35119000.00
CLYM cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 841000.00
CLYM cash_flow (annual, 2023-12-31) — Purchase Of Investment: -58449000.00
CLYM balance_sheet (annual, 2023-12-31) — Receivables: 2464000.00
CLYM income_statement (annual, 2023-12-31) — Research And Development: 15411000.00
CLYM balance_sheet (annual, 2023-12-31) — Retained Earnings: -155979000.00
CLYM cash_flow (annual, 2023-12-31) — Sale Of Investment: 127430000.00
CLYM income_statement (annual, 2023-12-31) — Selling General And Administration: 24864000.00
CLYM balance_sheet (annual, 2023-12-31) — Share Issued: 27699446.00
CLYM income_statement (annual, 2023-12-31) — Special Income Charges: 0.00
CLYM cash_flow (annual, 2023-12-31) — Stock Based Compensation: 12806000.00
CLYM balance_sheet (annual, 2023-12-31) — Stockholders Equity: 107599000.00
CLYM balance_sheet (annual, 2023-12-31) — Tangible Book Value: 107599000.00
CLYM income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLYM income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLYM balance_sheet (annual, 2023-12-31) — Taxes Receivable: 2024000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Assets: 110469000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Capitalization: 107599000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Debt: 349000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 107599000.00
CLYM income_statement (annual, 2023-12-31) — Total Expenses: 40275000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2870000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 214000.00
CLYM balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 37000.00
CLYM income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -40275000.00
CLYM income_statement (annual, 2023-12-31) — Total Unusual Items: 536000.00
CLYM income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 536000.00
CLYM balance_sheet (annual, 2023-12-31) — Working Capital: 107422000.00
CLYM balance_sheet (quarterly, 2024-09-30) — Accrued Interest Receivable: 990000.00
CLYM cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
CLYM cash_flow (quarterly, 2024-09-30) — Common Stock Issuance: 0.00
CLYM balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 29000.00
CLYM cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 0.00
CLYM cash_flow (quarterly, 2024-09-30) — Net Common Stock Issuance: 0.00
CLYM cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: 0.00
CLYM cash_flow (quarterly, 2024-09-30) — Net PPE Purchase And Sale: 0.00
CLYM balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 361000.00
CLYM income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: 2785000.00
CLYM cash_flow (quarterly, 2024-09-30) — Purchase Of PPE: 0.00
CLYM balance_sheet (quarterly, 2024-09-30) — Receivables: 990000.00
CLYM income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
CLYM balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 0.00
CLYM income_statement (annual, 2024-12-31) — +Operating Expense: 30361000.00
CLYM income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Accounts Payable: 705000.00
CLYM balance_sheet (annual, 2024-12-31) — Accrued Interest Receivable: 1119000.00
CLYM balance_sheet (quarterly, 2024-12-31) — Accrued Interest Receivable: 1119000.00
CLYM balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 441727000.00
CLYM cash_flow (annual, 2024-12-31) — Amortization Of Securities: -757000.00
CLYM cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CLYM cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 61610000.00
CLYM income_statement (annual, 2024-12-31) — Basic Average Shares: 48298693.00
CLYM income_statement (annual, 2024-12-31) — Basic EPS: -1.53
CLYM cash_flow (annual, 2024-12-31) — Beginning Cash Position: 93112000.00
CLYM balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 532000.00
CLYM balance_sheet (annual, 2024-12-31) — Capital Stock: 7000.00
CLYM balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 87229000.00
CLYM balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 150919000.00
CLYM balance_sheet (annual, 2024-12-31) — Cash Equivalents: 87229000.00
CLYM balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 87229000.00
CLYM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 130729000.00
CLYM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -121092000.00
CLYM cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: -15562000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Account Payable: -1140000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 1445000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -200000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -349000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Payable: -1140000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 305000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1942000.00
CLYM cash_flow (annual, 2024-12-31) — Change In Working Capital: 1698000.00
CLYM cash_flow (annual, 2024-12-31) — Changes In Cash: -5925000.00
CLYM balance_sheet (annual, 2024-12-31) — Common Stock: 7000.00
CLYM balance_sheet (annual, 2024-12-31) — Common Stock Equity: 211881000.00
CLYM cash_flow (annual, 2024-12-31) — Common Stock Issuance: 119750000.00
CLYM cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CLYM balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 3980000.00
CLYM balance_sheet (annual, 2024-12-31) — Current Assets: 154872000.00
CLYM balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 157000.00
CLYM balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 157000.00
CLYM balance_sheet (annual, 2024-12-31) — Current Liabilities: 4931000.00
CLYM cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 0.00
CLYM cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 0.00
CLYM income_statement (annual, 2024-12-31) — Diluted Average Shares: 48298693.00
CLYM income_statement (annual, 2024-12-31) — Diluted EPS: -1.53
CLYM income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -73897000.00
CLYM income_statement (annual, 2024-12-31) — EBIT: -30361000.00
CLYM income_statement (annual, 2024-12-31) — EBITDA: -30361000.00
CLYM cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 42000.00
CLYM cash_flow (annual, 2024-12-31) — End Cash Position: 87229000.00
CLYM cash_flow (annual, 2024-12-31) — Financing Cash Flow: 130729000.00
CLYM cash_flow (annual, 2024-12-31) — Free Cash Flow: -15562000.00
CLYM income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -9000.00
CLYM balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 23000.00
CLYM income_statement (annual, 2024-12-31) — General And Administrative Expense: 16025000.00
CLYM balance_sheet (annual, 2024-12-31) — Gross PPE: 689000.00
CLYM income_statement (annual, 2024-12-31) — Interest Income: 8132000.00
CLYM income_statement (annual, 2024-12-31) — Interest Income Non Operating: 8132000.00
CLYM balance_sheet (annual, 2024-12-31) — Invested Capital: 211881000.00